Nick de Cent
Nick de Cent
Latest posts from :
What happens when you take the combined portfolios of GSK and Pfizer and build...
What do you do when you see your business under threat? Respected consultant,...
Tom Abbott and Kumar Ramananda from technology specialist HCL discuss how to...
A new whitepaper explores the evolution of the KAM model among leading pharma...
Alzheimer’s disease has traditionally been a hidden condition in the...
As KAM expertise builds, pharma is heading for a sales transformation,...
A combination of deep customer insight, proper segmentation and an integrated...
Agnitio CEO, Morten Hjelmsoe maps out the three steps on the path to true...
Despite a perception that sales force effectiveness is dead, a return to...
Global Head of KAM, Jan Schluechter from Novartis talks to Nick de Cent about...